Introduction
Right ventricular (RV) systolic dysfunction is an important determinant of symptoms and a powerful marker of poor prognosis in patients with chronic heart failure.
1 -8 Although data have been collected primarily in patients with heart failure with reduced ejection fraction (HFrEF), more recently the interest of researchers has focused on patients heart failure with preserved ejection fraction (HFpEF). 9 -12 In contrast, the issue of which factors contribute to RV dysfunction in heart failure patients is still under scrutiny. It seems reasonable to hypothesize that there is a spectrum of clinical phenotypes evolving from one to the other, from isolated left ventricular (LV) dysfunction with normal pulmonary pressures to progressively more advanced conditions where RV dysfunction is the key determinant of prognosis. 13 However, it cannot be ruled out that specific mediators may have a different clinical role in the different contexts of HFrEF vs. HFpEF. Recognition of the factors associated with RV dysfunction is meaningful to better determine the pathophysiological metrics typical of both conditions, to improve prognostication, to target the specific mediators of RV dysfunction and, therefore, possibly, to develop more effective therapeutic strategies in heart failure patients.
In the present multicentre study we aimed at defining the clinical and echocardiographic correlates of RV dysfunction in a large population of heart failure patients with a broad range of LV systolic function. Right ventricular function was defined by echocardiography taking tricuspid annular plane systolic excursion (TAPSE) as the simplest and most robust indicator of RV dysfunction. For prognostic purposes we calculated the ratio of TAPSE to pulmonary artery systolic pressure (PASP), which has been proposed as a simplified indicator of the right ventricle to pulmonary circulation coupling. 7 The notion that load-independent indices of RV function may provide more efficient prognostic information in heart failure than the conventional RV echocardiographic parameters is currently taking hold among researchers also in acute decompensated heart failure.
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Methods
Study patients
The present study is a retrospective evaluation of a cohort of 1663 patients with chronic heart failure evaluated in 11 Italian Hospitals between January 2004 and December 2014. Inclusion criteria were: aetiology caused by coronary artery disease, or hypertensive heart disease, or idiopathic cardiomyopathy; stable clinical conditions over the last 3 months; and age > 18 years. Heart failure was defined by cardiologist-adjudicated heart failure diagnosis according to the Framingham criteria. 15 Patients were defined as having HFrEF if left ventricular ejection fraction (LVEF) was <40%, heart failure with mid-range ejection fraction (HFmrEF) if LVEF was 40-49%, and HFpEF if LVEF was ≥50%, according to the 2016 European heart failure guidelines. 16 Coronary artery disease was diagnosed on the basis of documented previous myocardial infarction or significant disease on coronary arteriography. Exclusion criteria were: myocardial infarction, or coronary artery bypass graft, or percutaneous coronary angioplasty in the previous 3 months; implantation of a cardiac resynchronization device in the previous 6 months; organic valvular heart disease; history of pulmonary embolism and any life-threatening condition with adverse prognosis other than cardiovascular disease; and any disease causing precapillary pulmonary hypertension. Demographic, clinical, laboratory, and echocardiographic data were collected in patients at study entry. The study was approved by the local institutional review boards and patients gave written informed consent. The study endpoint was all-cause mortality; survival data were obtained through follow-up visits of patients or, in the case of missed visits, through telephone contact.
Echocardiography
A standard transthoracic two-dimensional and Doppler echocardiographic examination was carried out with commercial equipment. Parameters were categorized as follows: a deceleration time of the E-wave (DT) <140 ms was used to define a restrictive LV filling pattern in HFrEF patients; an E/e ′ (at septal level) ratio ≥15 was used to define severe diastolic dysfunction in HFpEF and in HFmrEF patients. 17 Patients were categorized as having high PASP if the PASP estimate was >40 mmHg (PASP was obtained as the transtricuspid pressure gradient + the estimate of right atrial pressure based on inferior vena cava diameter and collapsibility). The cut-off for RV dysfunction was set at a TAPSE value of ≤14 mm vs. >14 mm as this threshold is associated with a strong impact on prognosis in the literature. 3, 8 TAPSE/PASP was categorized as <0.36 mm/mmHg vs. ≥0.36 mm/mmHg. 7 The end-diastolic volume index was categorized at its median value. Mitral regurgitation was categorized into four groups based on the evaluation of the jet area within the left atrium. For patients in atrial fibrillation (AF), all measurements were repeated at least three times and the average value was calculated.
Statistical analysis
Data were described as mean and standard deviation (SD) if continuous and as counts and per cent if categorical. The main echocardiographic parameters were categorized as described above. According to surface electrocardiogram (ECG), patients were classified as sinus rhythm or AF/PM in case of AF/flutter or ventricular stimulation (PM). The remaining continuous variables were dichotomized at their median value in the whole cohort. Correlation between continuous variables was computed with the Pearson R coefficient. Univariable and multivariable analysis was performed to identify the correlates of RV dysfunction. The variables tested include those hypothesized a priori to cause or contribute to RV dysfunction, including age, sex, history of coronary artery disease, rhythm, heart rate, LVEF, DT (and E/e ′ in HFpEF and in HFmrEF patients), PASP. Odds ratios (OR) and their 95% confidence intervals (CI) were computed by means of logistic models. This analysis was performed in the whole population and separately in the three subgroups with HFrEF, or HFmrEF, or HFpEF. Model discrimination was assessed by the area under the receiver operating characteristic curve (AUC ROC) of the model together with its 95% CI. Centre heterogeneity was considered by computing Huber-White robust standard errors while clustering for centres.
Cumulative survival was calculated on the basis of Kaplan-Meier estimates; the end-point of survival analysis was all-cause death. Cox univariable and multivariable analysis was performed to identify the independent predictors of survival. Two analysis were performed: the first included the following variables: age, sex, New York Heart Association (NYHA) class, coronary artery disease, systolic blood pressure, rhythm, heart rate, mitral regurgitation, furosemide dose, therapy with beta-blockers, therapy with angiotensin-converting enzyme HFrEF, heart failure with reduced ejection fraction; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; CAD, coronary artery disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; AF, atrial fibrillation; NYHA, New York Heart Association; BNP, brain natriuretic peptide; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blockers; ICD, implantable cardioverter defibrillator; LV EDVi, left ventricular end-diastolic volume index; DT, E-wave deceleration time; TAPSE, tricuspid annular plane systolic excursion; PASP, pulmonary artery systolic pressure.
(ACE) inhibitors/angiotensin receptor antagonists, end-diastolic volume index, DT, TAPSE, and PASP. In the second analysis, TAPSE and PASP were replaced by the TAPSE/PASP ratio. The relative risk of dying and its 95% CI were computed. As the number of patients in the HFpEF and HFmrEF groups was substantially smaller than in the HFrEF group, and the results of the above analysis showed that the correlates of RV dysfunction were similar in patients in the HFpEF and HFmrEF groups, these two groups were pooled for survival analysis. Model discrimination was assessed by the Harrell's C-statistics. For all models, the interaction with LVEF groups was tested with the likelihood ratio test (the model with the interaction was compared with the model without). Stata 14.1 (Stata Corporation, College Station, TX, USA) was used for computation. A two-sided P-value <0.05 was considered statistically significant. 
Results
Clinical characteristics
Correlates of right ventricular dysfunction
In the entire population LVEF <40% (OR 3.14, 95% CI 2.32-4.26, P < 0.001), coronary artery disease (OR 1.69, 95% CI 1.18-2.44, P = 0.005), AF/PM (OR 1.76, 95% CI 1.30-2.39, P < 0.001), heart rate >70 b.p.m. (OR 1.52, 95% CI 1.15-2.00, P = 0.003), a restrictive mitral inflow pattern (OR 2.38, 95% CI 1.33-4.35, P = 0.003), and PASP >40 mmHg (OR 2.26, 95% CI 1.14-4.46, P = 0.019) showed an independent association with RV dysfunction. The independent predictors of TAPSE ≤14 mm in the HFrEF, in the HFmrEF, and in the HFpEF groups are shown in Table 2 . In HFrEF the correlates of TAPSE ≤14 mm were the same as in the entire population, with the exception of heart rate and PASP which did not reach statistical significance (for heart rate >70 b.p.m.: OR 1.30, 95% CI 0.92-1.85, P = 0.142; for PASP >40 mmHg: OR 1.78, 95% CI 0.96-3.31, P = 0.067). In the HFpEF and HFmrEF groups, non-sinus rhythm, heart rate >70 b.p.m., end-diastolic volume greater than median value and PASP >40 mmHg were found to be independently associated with a TAPSE ≤14 mm; notably, in both groups PASP >40 mmHg carried an extremely high risk for RV dysfunction. A formal interaction analysis was performed and the results of this analysis confirmed that the phenotype of LV dysfunction (HFrEF, or HFpEF, or HFmrEF) modifies significantly (P = 0.0011) the relationship between TAPSE and PASP. Coronary artery disease was associated with a higher risk of RV dysfunction in HFrEF but not in HFpEF patients and was associated with a significantly lower risk of RV dysfunction in HFmrEF patients ( Table 2) ; interaction analysis was statistically significant (P = 0.0010). A DT ≤140 ms was associated with a higher risk of RV dysfunction in HFrEF but not in HFpEF or HFmrF patients ( Table 2) ; interaction analysis was not statistically significant (P = 0.6126). As shown in Figure 1 , the proportion of HFpEF and HFmrEF patients with a reduced TAPSE was negligible in the absence of high PASP, whereas a substantial proportion of HFrEF patients had a reduced TAPSE in the presence of normal PASP.
Prognostic significance of right ventricular dysfunction
Two hundred and fifty-eight patients died during a median follow-up period of 56 months. The independent predictors of survival at multivariable analysis for the HFrEF group and for the HFpEF and HFmrEF groups are shown in Table 3 using TAPSE and PASP separately and in Table 4 using the TAPSE/PASP ratio. Owing to the strict relationship between TAPSE and PASP in patients with LVEF ≥40%, TAPSE was not an independent predictor of prognosis in such patients when PASP was entered first in the multivariable model; the opposite was also true, as PASP was not an independent predictor of prognosis in such patients when TAPSE was entered first in the multivariable model. The TAPSE/PASP ratio allowed us obtain good values of Harrell's C-coefficient in both groups. Figure 2 shows survival for HFrEF patients and for HFmrEF and HFpEF patients according to the TAPSE/PASP ratio. There was no interaction between LVEF groups and results of survival analysis (P = 0.8818).
Discussion
The main finding of the present study is the demonstration that the clinical and echocardiographic correlates of a dysfunctioning right ventricle differ in heart failure patients according to the extent of LV systolic dysfunction. In particular, pulmonary hypertension is by far the strongest correlate in HFpEF and HFmrEF patients whereas it is not statistically significant in HFrEF. Dysfunction of the right ventricle is a powerful predictor of poor prognosis regardless of the extent of LV systolic dysfunction.
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Correlates of right ventricular dysfunction
The presence of an elevated pressure level in the pulmonary circulation has traditionally been considered a plausible cause for RV dysfunction in heart failure patients. This hypothesis has a sound pathophysiological background. 18, 19 However, in a substantial proportion of HFrEF patients, RV function may be reduced despite normal pulmonary artery pressures. Information on the determinants of RV dysfunction is poorer in HFpEF. 12 To our knowledge, the present study is the first specifically planned to evaluate the clinical and echocardiographic correlates of RV dysfunction in patients having HFrEF, or HFmrEF, or HFpEF. The first parameter correlated with RV dysfunction is LV systolic function itself: having a LVEF <40% was associated with a more than threefold increased risk of having a reduced TAPSE. Pure physiological considerations could explain this result; the right and the left ventricles share the same visceral cavity (the pericardium), have common myofibres, and [heart failure with reduced ejection fraction (HFrEF) patients] and normal pulmonary artery systolic pressure (PASP), patients with LVEF <40% and high PASP, patients with LVEF ≥40% [heart failure with preserved ejection fraction (HFpEF) and heart failure with mid-range ejection fraction (HFmrEF) patients] and normal PASP, patients with LVEF ≥40% and high PASP. strong ventriculo-ventricular interactions have been well demonstrated in isolated ventricles. 20, 21 In addition, the aetiology of the disease was another main determinant of RV dysfunction as coronary artery disease was associated with a higher risk of RV dysfunction in the entire population and in the subgroup with HFrEF. In contrast, it was not associated with RV dysfunction in HFpEF patients and it was associated with a significantly lower risk of RV dysfunction in HFmrEF patients. A plausible explanation is that large myocardial infarctions involving the left ventricle and the right ventricle are a common cause of biventricular dysfunction in heart failure patients. In contrast, HFpEF is a far more heterogeneous clinical syndrome than HFrEF and coronary artery disease is not its most frequent cause; whether there are specific HFpEF phenotypes in which the right ventricle is more extensively affected is at present unknown. The reasons why a restrictive LV filling pattern seen with Doppler echocardiography was associated with a . greater risk of RV dysfunction in HFrEF but not in the other patients are not obvious; however, this observation is in agreement with the invasive evaluation performed by Aschauer et al., 12 who found, using cardiac magnetic resonance, that pulmonary artery wedge pressure was similar in HFpEF patients with or without RV dysfunction. Pulmonary hypertension was associated with a markedly increased risk of reduced TAPSE in HFmrEF and HFpEF patients whereas it was not an independent risk factor for RV dysfunction in HFrEF patients. The relationship between PASP and TAPSE depicted in Figure 1 is particularly informative, showing that in patients having a LVEF ≥40% the prevalence of a reduced TAPSE is negligible when PASP is normal, whereas a substantial proportion of HFrEF patients may have a reduced TAPSE even in the absence of high pulmonary pressures. The observation that RV dysfunction is strongly associated with the presence of an elevated RV afterload in HFpEF and HFmrEF is particularly important. It may be considered as the pathophysiological background to previous observations on the prognostic role of pulmonary hypertension in patients with HFpEF. 22 In addition, it also provides a strong rationale for the necessity of discovering effective treatments for pulmonary hypertension in such patients. 23 The observation that AF and permanent RV pacing are strongly related to RV dysfunction in HFrEF, HFmrEF, and HFpEF patients is in agreement with previous suggestions that the mechanical function of the atria and ventricles are closely coupled on the right side of the heart and highlights the relevance of RV dyssynchrony, which is an issue that is largely underestimated.
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Prognostic role of right ventricular dysfunction
Right ventricular dysfunction is a known critical determinant of functional capacity and prognosis in heart failure patients, regardless of the degree of LV dysfunction. Importantly, over recent years it has been shown that taking into account the coupling between pulmonary artery pressure and RV function improves prognostic stratification of heart failure patients. 4, 7, 8 The present study confirms and expands previous observation, as it demonstrates that this coupling is different according to the phenotype of LV dysfunction: in HFpEF and HFmrEF patients TAPSE and PASP are so strictly related that when PASP is first included in the multivariable model, TAPSE turns out to be statistically irrelevant and vice versa. This does not mean that RV function is not important for prognostic stratification in such patients; on the contrary, these data further support the notion that load-independent indexes of RV function may provide more efficient clinical information in HF than conventional RV echocardiographic parameters. Whether the ratio of TAPSE to PASP should be used or the product of TAPSE times the transtricuspid systolic gradient, as more recently proposed in NYHA class IV patients admitted for acute decompensated HF, is an issue that deserves to be addressed in future studies.
Limitations
The quantitative assessment of RV structure and function is challenging and cardiac magnetic resonance imaging is the most accurate technique to quantify RV size and function. However, the limited access to the technology and the quite common contraindication in presence of implanted devices make magnetic resonance less suitable than echocardiography for multicentre studies involving large cohorts of patients. A thorough description of the structure and function of the right ventricle at echocardiography requires the analysis of several parameters (including RV areas and fractional area change, RV free wall thickness, degree of tricuspid regurgitation, right atrial area) in addition to the TAPSE which has been evaluated in the present study. Nonetheless, a reduced TAPSE has been linked to mortality in several previous studies in heart failure patients and it can be considered a robust marker of prognosis, even in specific cardiomyopathies, such as cardiac amyloidosis. 25 In the future we need a prospective study aimed at identifying which is the most useful single echo parameter or combination of echo parameters to study the right ventricle in heart failure patients. We acknowledge that quantification of ventriculo-arterial coupling requires complex invasive measurements with conductance catheters and varying loading conditions. 26 The TAPSE/PASP ratio . is a simple non-invasive estimate that allows the application of this concept in clinical practice. Distinguishing between isolated postcapillary and combined precapillary and postcapillary pulmonary hypertension could be important as it could be related to the development of RV dysfunction and failure; however, such distinction is not feasibly accurate using echocardiography. Finally, the duration of the disease and the duration of pulmonary hypertension could both be important determinants of RV dysfunction but both are extremely difficult to assess in clinical practice.
Conclusions
The present study identified clinical and echocardiographic factors associated with RV dysfunction in heart failure, highlighting differences between HFrEF and HFpEF and HFmrEF patients, which might have relevant implications for future research. In clinical practice, the present results suggest putting more effort into the reduction in pulmonary artery pressures to improve RV function in heart failure patients with preserved or mid-range LV systolic function and confirm that combining the information on RV function and pulmonary artery pressures in a single TAPSE/PASP ratio allows one to obtain an accurate risk stratification in all heart failure patients.
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